| ID Source | ID |
|---|---|
| PubMed CID | 165028 |
| SCHEMBL ID | 180332 |
| MeSH ID | M0068071 |
| Synonym |
|---|
| 4-guanidinophenylalanine |
| 2776-36-5 |
| FYMNTAQFDTZISY-QMMMGPOBSA-N |
| para-guanidinophenylalanine |
| p-guanidino-l-phenylalanine |
| phenylalanine, 4-((aminoiminomethyl)amino)- |
| SCHEMBL180332 |
| p-guanidino phenylalanine |
| 59574-11-7 |
| (s)-2-amino-3-(4-guanidinophenyl)propanoic acid |
| (2s)-2-amino-3-(4-carbamimidamidophenyl)propanoic acid |
| (s)-2-amino-3-(4-guanidinophenyl)propanoicacid |
| DTXSID70950447 |
| 4-carbamimidamidophenylalanine |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||